New hope for lung cancer patients with brain metastases
NCT ID NCT07197008
Summary
This study is testing whether a new two-drug combination can help control advanced lung cancer that has spread to the brain after other targeted treatments have stopped working. It will enroll 50 patients with a specific genetic type of lung cancer to see if the treatment shrinks brain tumors and is safe. The main goal is to measure how many patients see their brain tumors get smaller.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.